2019 Editorial articles
- What have we learned from DAPA-HF? ( 01/12/2019 )
- The COACT trial – finally the over worked interventionalist catches a break? ( 30/10/2019 )
- 3D transthoracic echocardiography for left ventricular assessment - ready for prime time? ( 30/10/2019 )
- Atrial fibrillation - a ‘large’ problem? ( 26/09/2019 )
- Arrhythmias in Pregnancy ( 23/05/2019 )
- Coronary physiology: the next step for interventional cardiology ( 23/05/2019 )
- Coronary microvascular dysfunction - a closer look ( 10/05/2019 )
- Review of acute pulmonary embolism management and the evidence on intermediate-high risk PE ( 09/05/2019 )
- Is it now time for TAVI to be the default treatment for all patients with severe aortic stenosis? ( 23/04/2019 )
- PARTNER 3 - the death knell for surgical aortic valve replacement? ( 23/04/2019 )
- Troponin rise in sepsis…who gets an angiogram? ( 18/04/2019 )
- Is it time to follow the guidelines and go OAC alone one year after PCI in patients with AF? ( 12/04/2019 )
- The future of lithotripsy – not just for the kidneys ( 12/04/2019 )
- TAVR in low risk severe AS has landed: what remains uncertain? ( 12/04/2019 )
- Computed Tomography Coronary Angiography in Stable Coronary Heart Disease: the UK perspective ( 29/03/2019 )
- Magnetic Resonance Imaging in Patients with Cardiac Implantable Electronic Devices: Current Recommendations ( 29/03/2019 )
- Women in cardiology: where are we now? ( 29/03/2019 )
- Is FFRCT the answer to our prayers? ( 29/03/2019 )
- Cardiac contractility modulation (CCM) in chronic heart failure: mechanistic insights and clinical implications ( 19/03/2019 )
- Cardiac Device Infection Prevention ( 19/03/2019 )
- Reducing caffeine for treatment of arrhythmias - myth or evidence-based medicine? ( 15/03/2019 )
- Sacubitril/Valsartan: Where are we now? ( 15/03/2019 )
- BASILICA – A classical name for a novel solution ( 11/02/2019 )
- The evolving field of Hybrid Imaging in Cardiology ( 31/01/2019 )
- LDL cholesterol: How low should you go? Insights from ODYSSEY OUTCOMES trial ( 31/01/2019 )
- Is the largest randomised controlled trial for Infective Endocarditis “POET” a practice changer? A review of IE treatment. ( 31/01/2019 )
- What is preserved LV ejection fraction in aortic stenosis: 0.50, 0.55 or 0.60? ( 31/01/2019 )
- Structured Approach in Syncope ( 17/01/2019 )